N.M. Admin. Code § 16.12.9.7

Current through Register Vol. 35, No. 21, November 5, 2024

Section 16.12.9.7 - DEFINITIONS

A.Definitions beginning with "A":

(1)"acute pain", means the normal, predicted physiological response to a noxious chemical or thermal or mechanical stimulus, typically associated with invasive procedures, trauma or disease and generally time limited;

(2)"addiction", is a neurobehavioral syndrome with genetic and environmental influences that results in psychological dependence on the use of substances for their psychic effects. It is characterized by behaviors that include one or more of the following: impaired control over drug use; compulsive use; continued use despite harm; and craving. Physical dependence and tolerance are normal physiological consequences of extended opioid therapy for pain and should not by themselves be considered addiction.

B.Definitions beginning with "B": [RESERVED]

C.Definitions beginning with "C":

(1)"chronic pain" means pain that persists after reasonable efforts have been made to relieve the pain or its cause and that continues, either continuously or episodically, for longer than three consecutive months. "Chronic pain" does not, for the purpose of the Pain Relief Act requirements, include pain associated with a terminal condition or with a progressive disease that, in the normal course of progression, may reasonably be expected to result in a terminal condition;

(2)"clinical expert" means a person who, by reason of specialized education or substantial relevant experience in pain management, has knowledge regarding current standards, practices and guidelines.

D.Definitions beginning with "D": "drug abuser" means a person who takes a drug or drugs for other than legitimate medical purposes.

E.Definitions beginning with "E": [RESERVED]

F.Definitions beginning with "F": [RESERVED]

G.Definitions beginning with "G": [RESERVED]

H.Definitions beginning with "H": [RESERVED]

I. Definitions beginning with "I": [RESERVED]

J.Definitions beginning with "J": [RESERVED]

K.Definitions beginning with "K": [RESERVED]

L.Definitions beginning with "L": [RESERVED]

M.Definitions beginning with "M": [RESERVED]

N.Definitions beginning with "N": "nursing facility" means a long term care facility in which the patient is a current fulltime resident and whose medications are solely administered and managed by the facility.

O.Definitions beginning with "O":

(1)"opioid analgesic" means buprenorphine, butorphanol, codeine, hydrocodone, hydromorphine, levorphanol, meperidine, methadone, morphine, nalbuphine, oxycodone, oxymorphone, pentazocine and propoxyphene as well as their brand names, isomers and combinations;

(2)"opioid antagonist" means a drug approved by the federal food and drug administration that when administered negates or neutralizes in whole or in part the pharmacological effects of an opioid analgesic in the body, including naloxone and such other medications approved by the board of pharmacy for the reversal of opioid analgesic overdoses.

P.Definitions beginning with "P":

(1)"pain" means an unpleasant sensory and emotional experience associated with inflammation or with actual or potential tissue damage, or described in terms of such inflammation and damage, which could include acute, persistent or chronic pain;

(2)"physical dependence" means a state of adaptation that is manifested by a drug-specific withdrawal syndrome that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug, administration of an antagonist, or a combination of these;

(3)"prescription monitoring program (PMP)" means a centralized system to collect, monitor, and analyze electronically, for controlled substances, prescribing and dispensing data submitted by pharmacies and dispensing practitioners. The data are used to support efforts in education, research, enforcement and abuse prevention.

Q.Definitions beginning with "Q": [RESERVED]

R.Definitions beginning with "R": [RESERVED]

S.Definitions beginning with "S": [RESERVED]

T.Definitions beginning with "T":

(1)"therapeutic purpose" means the use of pharmaceutical and non-pharmaceutical treatments and the spectrum of available modalities that conforms substantially to accepted guidelines for pain management.

(2)"tolerance" means a state of adaptation in which exposure to a drug induces changes that result in a diminution of one or more of the drug's effects over time.

U.Definitions beginning with "U": [RESERVED]

V.Definitions beginning with "V": [RESERVED]

W.Definitions beginning with "W": [RESERVED]

X.Definitions beginning with "X": [RESERVED]

Y.Definitions beginning with "Y": [RESERVED]

Z.Definitions beginning with "Z": [RESERVED]

N.M. Admin. Code § 16.12.9.7

16.12.9.7 NMAC - N, 02-17-06; A, 11-20-12, Amended by New Mexico Register, Volume XXVIII, Issue 17, September 12, 2017, eff. 9/12/2017, Adopted by New Mexico Register, Volume XXXV, Issue 10, May 21, 2024, eff. 5/21/2024